SOCRATES-REDUCED
Phase IIb safety and efficacy study of four dose regimens of BAY 1021189 in patients with HFpEF suffering from worsening HF (SOCRATES-REDUCED)
- Stage
- klaar
- Medicine
- BAY-1021189
- Population
- Hartfalen
- Phase
- IIb
- First Patient In
- 15 November 2013
- Last Patient In
- 1 January 2015
- Last Patient Last Visit
- -
Board Contact
